Myopia Control Using Optimized Optical Defocus RCTs
1 other identifier
interventional
167
1 country
1
Brief Summary
The aims of the study is to evaluate whether the DISC3.5 Plus contact lens will slow myopia progression and axial length growth in myopic children as compared with single vision soft contact lenses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2018
CompletedFirst Posted
Study publicly available on registry
September 24, 2018
CompletedStudy Start
First participant enrolled
October 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2022
CompletedAugust 24, 2022
August 1, 2022
2.5 years
September 20, 2018
August 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cycloplegic Refraction Change in SER
Change in cycloplegic autorefraction in spherical equivalent (SER)
12 months
Secondary Outcomes (1)
Axial length
12 months
Study Arms (2)
Single vision soft contact lens
NO INTERVENTIONsingle vision, spherical soft contact lens
DISC3.5 Plus lens
EXPERIMENTALA soft contact lens that comprises of simultaneous distance optical prescription and myopic defocus areas.
Interventions
The Defocus Incorporated Soft 3.5 Plus Contact Lens (DISC3.5 Plus) is a soft contact lens that comprises of simultaneous distance optical prescription and myopic defocus areas.
Eligibility Criteria
You may qualify if:
- Age at enrolment: 8-13 year; Hong Kong Chinese
- Spherical equivalent refractions (SER): -1.00 to -5.00D
- Astigmatism: -1.00D or less
- Anisometropia: 1.25D or less
- Spectacle corrected monocular visual acuity (VA): 0.0 logMAR or better
- Contact lens corrected monocular VA: 0.1 logMAR or better
- Normal binocular function
- Willingness to wear contact lenses regularly
- Parents' understanding and acceptance of random allocation of grouping and masking
You may not qualify if:
- Prior myopia control treatment, e.g. orthokeratology, defocus soft contact lenses, progressive addition lenses, bifocal lenses, drugs (e.g. atropine), etc.
- Strabismus or decompensated phoria (checked by cover test at far and near in screening)
- Known contraindications for contact lens wear
- Have any ocular and systemic diseases and abnormalities that might affect visual function or refractive development
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Centre of Myopia Ressearch, School of Optometry, The Hong Kong PolyU
Hong Kong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carly SY Lam, phD
School of Optometry, The Hong Kong Polytechnic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Double masked design: The investigator(s) who were responsible for refracting and performing relevant ocular data measurement were masked from the grouping of the subjects. The unmasked investigator(s) were responsible for group allocation, spectacle-dispensing work, measuring lens visual performance, record keeping, data entry and compliance checking. Data input was carefully checked by the unmasked investigator and the other researchers independently. The children and their parents were also masked to group allocation until the data analysis was completed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 20, 2018
First Posted
September 24, 2018
Study Start
October 25, 2018
Primary Completion
May 8, 2021
Study Completion
June 24, 2022
Last Updated
August 24, 2022
Record last verified: 2022-08